Type 2 Diabetes: NNC9733-0001 Study
We are researching a new medicine, NNC9733-0001, in healthy individuals and those with type 2 diabetes. The goal is to learn more about its effects and potential benefits.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Type 2 Diabetes
Type 2 Diabetes (T2D) is a long-term condition where your body does not use insulin properly, leading to high blood sugar levels and symptoms like thirst, tiredness, and frequent urination.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Novo Nordisk A/S
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.